Effectiveness Brief Information Advanced Directives Primary Care
4 de octubre de 2017 actualizado por: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Effectiveness of a Brief Information About Advanced Directives in Primary Care: A Randomized Clinical Trial
The knowledge and completion of advanced directives (ADs) by the population is generally low. Primary care could develop a very important role to inform and assist in the preparation of this document because of its accessibility.
Objective: To evaluate the effectiveness of an oral brief information and a brochure administered in primary care to improve the proportion of ADs records.
Design: Randomized clinical trial. Ambit: 7 offices from a urban health center which serves about 25,000 users older than 18 years.
Material and methods It will be administered randomly triptych and oral brief information about the existence of advance directives for people over 18 to attend the appointment of their family doctor for any reason (intervention group). It will be given the possibility of more extensive information if they wish and collaboration will be offered for the advance directive according to patient preferences. The control group will not receive any information. Follow-up: 3 months. Variables will be: number of people interested in ADs, number of ADs made and demographic data (gender, age, education level, race, comorbidities, religion, testament) in both groups. Statistical analysis: multiple linear regression, Poisson and Cox as response analyzed, with the intervention/control group as the main variable adjusting for potential confounders. Bivariate comparison using Student t test or Mann-Whitney test (continuous variables) and chi-square or Fisher's exact test (categorical variables). 165 subjects were required in the control group and 165 in the intervention group.
Conclusion: positive results of this study will bring out the brief information managed by family physicians increases the number of ADs thus facilitating the right to autonomy of the patient.
Descripción general del estudio
Estado
Desconocido
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Anticipado)
330
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Barcelona
-
L'Hospitalet de Llobregat, Barcelona, España, 08905
- Reclutamiento
- Institu Català de la Salut
-
Contacto:
- Yolanda Rando
- Número de teléfono: +34616678030
- Correo electrónico: yolanrando@gmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Patients older than 18 years old who go to their family doctor by appointment.
Exclusion Criteria:
- - Patients with language barrier
- Patients younger than 18 years (advanced directives not provided for by law)
- Patients with altered decision-making ability according to computerized clinical history by coding in health problems or mentioned in a clinical course of computerized medical history : cognitive impairment, dementia, mental retardation diagnosed. Although there are studies on attitudes towards advanced directives of people with early cognitive impairment (Minimental> 18), it was decided to discard because the intervention should be brief. The cited study also concludes that this type of patients prefer to delegate decisions to the family.
- Patients who come spontaneously to their family doctor.
- Patients who have already been recruited previously in the study. Patients who may visit by appointment only on more than one occasion will only participate once and subsequent visits for recruitment will be excluded. In addition, there will be no reinforcement of the study intervention in these visits.
- Patients who have already formalized the advanced directives.
- Patients who do not wish to participate in the study.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Brief information group
Patients will be given brief information about the existence of advance directives after resolving the reason for the visit for which they had come.
This information will not last more than 3 minutes and will not be repeated on successive visits within the recruitment period.
Also, an informative triptych will be given to the patient so that he can read it at home.
These leaflets have been made by the regional Department of Health.
They will be advised that we can extend the information or help them to do the document in the near future if they want, we will inform that we would wait for the answer 3 months.
In case of interest, they can leave their information in the User Service by specifying name, telephone number and reference doctor or ask for an appointment again.
|
Patients will be given oral brief information about the existence of advance directives after resolving the reason for the visit for which they had come.
This information will not last more than 3 minutes and will not be repeated on successive visits within the recruitment period.
Also, an informative triptych will be given to the patient so that he can read it at home.
These leaflets have been made by the regional Department of Health.
They will be advised that we can extend the information or help them to do the document in the near future if they want, we will inform that we would wait for the answer 3 months.
In case of interest, they can leave their information in the User Service by specifying name, telephone number and reference doctor or ask for an appointment again.
|
|
Sin intervención: Control group
Patients who fall into a control group will only be attended to their reason for visiting and will be asked for the necessary data to obtain the independent variables if they do not appear in their history.
If the patient in this group wants the information, he will be excluded from the study because he "refuses to participate."
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Interest in or performance of advance directives
Periodo de tiempo: In 3 months
|
Proportion of people interested in or performance of Advance Directives in 3 months in the adult population.
They will be obtained at the moment that the patient shows interest in the intervention of when they performance the Advance Directives, or if not, by asking by appointment or by telephone within 3 months of their recruitment
|
In 3 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Baseline characteristics of those who perform or are interested in Advanced Directives
Periodo de tiempo: In 3 months
|
Evaluate the baseline characteristics of those who perform or are interested in Advanced Directives (whether they are in the control or intervention group).
|
In 3 months
|
|
Baseline characteristics of those performing Advanced directives in intervention group
Periodo de tiempo: In 3 months
|
To assess the baseline characteristics of those performing the Advanced Directives and those not within the intervention group
|
In 3 months
|
|
Reasons to performance Advanced directives
Periodo de tiempo: In 3 months
|
Evaluate the reasons why patients finally formalize the document by open question (will be categorized if there is a limited number of responses, otherwise the reasons will be described qualitatively).
|
In 3 months
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Investigadores
- Investigador principal: Yolanda Rando, Institut Català de la Salut
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
3 de noviembre de 2016
Finalización primaria (Anticipado)
31 de marzo de 2018
Finalización del estudio (Anticipado)
31 de marzo de 2018
Fechas de registro del estudio
Enviado por primera vez
18 de septiembre de 2017
Primero enviado que cumplió con los criterios de control de calidad
4 de octubre de 2017
Publicado por primera vez (Actual)
5 de octubre de 2017
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
5 de octubre de 2017
Última actualización enviada que cumplió con los criterios de control de calidad
4 de octubre de 2017
Última verificación
1 de septiembre de 2017
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 15/101
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Descripción del plan IPD
For confidentiality
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Brief information group
-
University of SalamancaTerminado
-
Assistance Publique - Hôpitaux de ParisAún no reclutandoPérdida de la audición | Función cognitiva | Función ejecutiva | Función vestibularFrancia
-
University of LisbonAssociacao Protectora dos Diabeticos de PortugalTerminado
-
Arizona Oncology ServicesDesconocidoCáncer de mama localizado | Cáncer de próstata localizado | Pacientes que reciben radioterapia de haz externoEstados Unidos
-
University of TennesseeNational Cancer Institute (NCI); Regional One HealthReclutamientoPérdida de peso | Sobrepeso y Obesidad | Comportamiento, SaludEstados Unidos
-
Boston Children's HospitalTerminadoEstrés Psicológico | Problema de aculturaciónEstados Unidos
-
Alberto PilottoAún no reclutandoPersonas mayores | Enfermedades Crónicas No Transmisibles
-
Population Health Research InstituteTerminadoPacientes con riesgo de trombosisCanadá
-
Assistance Publique - Hôpitaux de ParisAún no reclutandoTrastornos del neurodesarrollo
-
Amsterdam UMC, location VUmcRed Cross Hospital BeverwijkTerminadoCicatriz Hipertrófica | QueloidePaíses Bajos